Indofarma Tbk PT 

Rp126
3
+Rp0+0% Tuesday 20:00

统计数据

当日最高
126
当日最低
126
52周最高
725
52周最低
126
成交量
0
平均成交量
76,640
市值
2.56T
市盈率
-
股息收益率
-
股息
-

股息

0%股息收益率
10年增长
N/A
5年增长
N/A
3年增长
N/A
1年增长
N/A

收益

1May预期
Q2 2022
Q3 2022
Q3 2023
Q1 2024
-29.81
-24.13
-18.44
-12.76
预期每股收益
N/A
实际每股收益
N/A

人们还关注

此列表基于关注INAF.JK的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

关于

PT Indofarma Tbk, together with its subsidiaries, manufactures and markets pharmaceutical products in Indonesia. The company trades in and distributes drugs, medical devices, medical supplies, extracts, and herbals; and operates laboratory. It also provides COVID-19 test services, including rapid diagnostic test antigen; reverse transcription polymerase chain reaction, and genose. The company also exports its products. The company was formerly known as PT Indofarma (Persero) Tbk. PT Indofarma Tbk was founded in 1918 and is headquartered in Bekasi, Indonesia. PT Indofarma Tbk operates as a subsidiary of PT. Bio Farma.
Show more...
首席执行官
Mr. Arief Pramuhanto
员工
1179
国家
Indonesia
ISIN
ID1000068406

上市公司